Xortx Therapeutics (NASDAQ: XRTX) is owned by 0.01% institutional shareholders, 0.00% Xortx Therapeutics insiders, and 99.99% retail investors. Clearstead Advisors LLC is the largest individual Xortx Therapeutics shareholder, owning 277.00 shares representing 0.01% of the company. Clearstead Advisors LLC's Xortx Therapeutics shares are currently valued at $245.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.